204 related articles for article (PubMed ID: 22039044)
21. Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis.
Thiele S; Mungalpara J; Steen A; Rosenkilde MM; Våbenø J
Br J Pharmacol; 2014 Dec; 171(23):5313-29. PubMed ID: 25039237
[TBL] [Abstract][Full Text] [Related]
22. A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4.
Schoofs G; Van Hout A; D'huys T; Schols D; Van Loy T
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29578516
[TBL] [Abstract][Full Text] [Related]
23. Heterologous regulation of CXCR4 lysosomal trafficking.
Caballero A; Mahn SA; Ali MS; Rogers MR; Marchese A
J Biol Chem; 2019 May; 294(20):8023-8036. PubMed ID: 30936203
[TBL] [Abstract][Full Text] [Related]
24. G protein activation via chemokine (C-X-C motif) receptor 4 and α
Gao X; Majetschak M
FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
[TBL] [Abstract][Full Text] [Related]
25. The E3 ubiquitin ligase atrophin interacting protein 4 binds directly to the chemokine receptor CXCR4 via a novel WW domain-mediated interaction.
Bhandari D; Robia SL; Marchese A
Mol Biol Cell; 2009 Mar; 20(5):1324-39. PubMed ID: 19116316
[TBL] [Abstract][Full Text] [Related]
26. Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation.
Kufareva I; Stephens BS; Holden LG; Qin L; Zhao C; Kawamura T; Abagyan R; Handel TM
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5363-72. PubMed ID: 25468967
[TBL] [Abstract][Full Text] [Related]
27. Mapping the binding of the N-terminal extracellular tail of the CXCR4 receptor to stromal cell-derived factor-1alpha.
Gozansky EK; Louis JM; Caffrey M; Clore GM
J Mol Biol; 2005 Jan; 345(4):651-8. PubMed ID: 15588815
[TBL] [Abstract][Full Text] [Related]
28. Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4.
Perpiñá-Viciano C; Işbilir A; Zarca A; Caspar B; Kilpatrick LE; Hill SJ; Smit MJ; Lohse MJ; Hoffmann C
Mol Pharmacol; 2020 Aug; 98(2):72-87. PubMed ID: 32474443
[TBL] [Abstract][Full Text] [Related]
29. Human β-defensin-3 structure motifs that are important in CXCR4 antagonism.
Feng Z; Dubyak GR; Jia X; Lubkowski JT; Weinberg A
FEBS J; 2013 Jul; 280(14):3365-75. PubMed ID: 23659571
[TBL] [Abstract][Full Text] [Related]
30. Role of CXCR4 internalization in the anti-HIV activity of stromal cell-derived factor-1α probed by a novel synthetically and modularly modified-chemokine analog.
Dong CZ; Tian S; Madani N; Choi WT; Kumar S; Liu D; Sodroski JG; Huang Z; An J
Exp Biol Med (Maywood); 2011 Dec; 236(12):1413-9. PubMed ID: 22101518
[TBL] [Abstract][Full Text] [Related]
31. Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.
Stephens BS; Ngo T; Kufareva I; Handel TM
Sci Signal; 2020 Jul; 13(640):. PubMed ID: 32665413
[TBL] [Abstract][Full Text] [Related]
32. Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor.
Huang X; Shen J; Cui M; Shen L; Luo X; Ling K; Pei G; Jiang H; Chen K
Biophys J; 2003 Jan; 84(1):171-84. PubMed ID: 12524273
[TBL] [Abstract][Full Text] [Related]
33. Structural basis of the interaction between chemokine stromal cell-derived factor-1/CXCL12 and its G-protein-coupled receptor CXCR4.
Kofuku Y; Yoshiura C; Ueda T; Terasawa H; Hirai T; Tominaga S; Hirose M; Maeda Y; Takahashi H; Terashima Y; Matsushima K; Shimada I
J Biol Chem; 2009 Dec; 284(50):35240-50. PubMed ID: 19837984
[TBL] [Abstract][Full Text] [Related]
34. Sulfopeptide probes of the CXCR4/CXCL12 interface reveal oligomer-specific contacts and chemokine allostery.
Ziarek JJ; Getschman AE; Butler SJ; Taleski D; Stephens B; Kufareva I; Handel TM; Payne RJ; Volkman BF
ACS Chem Biol; 2013 Sep; 8(9):1955-63. PubMed ID: 23802178
[TBL] [Abstract][Full Text] [Related]
35. Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach.
Costantini S; Raucci R; De Vero T; Castello G; Colonna G
Cytokine; 2013 Oct; 64(1):316-21. PubMed ID: 23773308
[TBL] [Abstract][Full Text] [Related]
36. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
Hara T; Tanegashima K
Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
[TBL] [Abstract][Full Text] [Related]
37. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).
Veldkamp CT; Seibert C; Peterson FC; Sakmar TP; Volkman BF
J Mol Biol; 2006 Jun; 359(5):1400-9. PubMed ID: 16725153
[TBL] [Abstract][Full Text] [Related]
38. Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues.
Hoffmann F; Müller W; Schütz D; Penfold ME; Wong YH; Schulz S; Stumm R
J Biol Chem; 2012 Aug; 287(34):28362-77. PubMed ID: 22736769
[TBL] [Abstract][Full Text] [Related]
39. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
40. Critical role in CXCR4 signaling and internalization of the polypeptide main chain in the amino terminus of SDF-1α probed by novel N-methylated synthetically and modularly modified chemokine analogues.
Dong CZ; Tian S; Choi WT; Kumar S; Liu D; Xu Y; Han X; Huang Z; An J
Biochemistry; 2012 Jul; 51(30):5951-7. PubMed ID: 22779681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
